A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
Yiyin Zhang(Peking University), Si Shi(First Affiliated Hospital of Guangzhou Medical University)
Cited by 60
Related Papers
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
|Molecular Cancer|2021|2.2k
A blueprint for tumor-infiltrating B cells across human cancers
|Science|2024|199
A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance
|Theranostics|2020|169
Melatonin attenuates acute kidney ischemia/reperfusion injury in diabetic rats by activation of the SIRT1/Nrf2/HO-1 signaling pathway
|Bioscience Reports|2018|133
Multipoint targeting of the PI3K/mTOR pathway in mesothelioma
|British Journal of Cancer|2014|93